Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

2011 ◽  
Vol 30 (3) ◽  
pp. 1121-1131 ◽  
Author(s):  
Simona Lapusan ◽  
Maria B. Vidriales ◽  
Xavier Thomas ◽  
Stephane de Botton ◽  
Anne Vekhoff ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase I ◽  
Myeloid Leukemia ◽  
Adult Patients ◽  
Phase I Studies ◽  
Refractory Acute Myeloid Leukemia ◽  
Acute Myeloid

scholarly journals Phase I Study of Clofarabine in Adult Patients with Acute Myeloid Leukemia in Japan

2013 ◽  
Vol 43 (12) ◽  
pp. 1177-1183 ◽  
Author(s):  
T. Suzuki ◽  
T. Yamauchi ◽  
K. Ando ◽  
T. Nagai ◽  
K. Kakihana ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase I ◽  
Myeloid Leukemia ◽  
Phase I Study ◽  
Adult Patients ◽  
Acute Myeloid

scholarly journals Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia

Leukemia ◽  
2004 ◽  
Vol 19 (1) ◽  
pp. 141-143 ◽  
Author(s):  
Y Choi ◽  
H-J Kim ◽  
B-H Park ◽  
W-S Min ◽  
C-C Kim
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Adult Patients ◽  
Novel Mutations ◽  
Refractory Acute Myeloid Leukemia ◽  
Acute Myeloid

Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study

1989 ◽  
Vol 7 (4) ◽  
pp. 267-273 ◽  
Author(s):  
Wolfgang Hiddemann ◽  
Dieter Urbanitz ◽  
Peter Preusser ◽  
Wolf Achterrath ◽  
Thomas Büchner
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase I ◽  
Myeloid Leukemia ◽  
Clinical Phase ◽  
Refractory Acute Myeloid Leukemia ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document